化工社化工社 化学情報印刷レポート · 研究参考用
8-chlorodibenz[b,f][1,4]oxazepin-10(11H)carbonyl chloride → 8-chlorodibenz[b,f][1,4]oxazepine-10(11H)carboxylic acid
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | 8-chlorodibenz[b,f][1,4]oxazepin-10(11H)carbonyl chloride | HCID 14975983 | — |
| 反応物 | N-(methylsulfonyl)-L-phenylalanine, hydrazide | HCID 131718326 | — |
| 生成物 | 8-chlorodibenz[b,f][1,4]oxazepine-10(11H)carboxylic acid | HCID 21983467 | — |
反応手順
8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2,[2-[(methylsulfonyl)amino]-1-oxo-3-phenyl]hydrazide (15) was prepared in the manner described above in Example 5 on a 0.51 mmol scale starting with N-(methylsulfonyl)-L-phenylalanine, hydrazide (14), prepared as described above in Example 14, and 8-chlorodibenz[b,f][1,4]-oxazepine-10(11H)-carbonyl chloride (2), prepared as described above in Example 2, to yield 0.11 g (42%) of product.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US05393747 |
| 出典データセット | uspto-grants-1995_02 |
| ORD ID | ord-3b32e8c689a04fcb9c08536b5c1c1120 |
| 出典メモ | uspto-grants-1995_02 |